BPC-157

Research

Body Protection Compound 157

Aliases
PL 14736, Bepecin
Administration
Subcutaneous injection, Intramuscular injection, Oral (limited bioavailability)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Some users report early signs of reduced pain or discomfort at the site of injury as inflammation begins to settle.

  2. 2

    3–4 Weeks

    Mobility and range of motion may start to feel less restricted, particularly for soft-tissue injuries.

  3. 3

    5–7 Weeks

    Continued tissue repair may bring further reduction in discomfort during movement or exercise.

  4. 4

    8–10 Weeks

    For tendon and ligament-related use, users may notice increased tolerance for light activity or training.

  5. 5

    11–15 Weeks

    Structural healing continues in the background; day-to-day differences tend to feel less dramatic as tissue stabilizes.

  6. 6

    16–20 Weeks

    Any remaining stiffness or discomfort from the original injury may continue to gradually resolve.

  7. 7

    21–24 Weeks

    By this stage, most users evaluate whether the injury has reached its expected recovery plateau.

⚠️ Research context only. This is not medical advice and results are not guaranteed.